Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Aging Cell ; 22(8): e13866, 2023 08.
Article in English | MEDLINE | ID: mdl-37170475

ABSTRACT

Recent studies suggest that epigenetic rejuvenation can be achieved using drugs that mimic calorie restriction and techniques such as reprogramming-induced rejuvenation. To effectively test rejuvenation in vivo, mouse models are the safest alternative. However, we have found that the recent epigenetic clocks developed for mouse reduced-representation bisulphite sequencing (RRBS) data have significantly poor performance when applied to external datasets. We show that the sites captured and the coverage of key CpGs required for age prediction vary greatly between datasets, which likely contributes to the lack of transferability in RRBS clocks. To mitigate these coverage issues in RRBS-based age prediction, we present two novel design strategies that use average methylation over large regions rather than individual CpGs, whereby regions are defined by sliding windows (e.g. 5 kb), or density-based clustering of CpGs. We observe improved correlation and error in our regional blood clocks (RegBCs) compared to published individual-CpG-based techniques when applied to external datasets. The RegBCs are also more robust when applied to low coverage data and detect a negative age acceleration in mice undergoing calorie restriction. Our RegBCs offer a proof of principle that age prediction of RRBS datasets can be improved by accounting for multiple CpGs over a region, which negates the lack of read depth currently hindering individual-CpG-based approaches.


Subject(s)
DNA Methylation , Epigenomics , Mice , Animals , DNA Methylation/genetics , CpG Islands/genetics , Sequence Analysis, DNA/methods , Epigenesis, Genetic
3.
Clin Epigenetics ; 13(1): 170, 2021 09 06.
Article in English | MEDLINE | ID: mdl-34488874

ABSTRACT

Ageing is an inevitable condition that afflicts all humans. Recent achievements, such as the generation of induced pluripotent stem cells, have delivered preliminary evidence that slowing down and reversing the ageing process might be possible. However, these techniques usually involve complete dedifferentiation, i.e. somatic cell identity is lost as cells are converted to a pluripotent state. Separating the rejuvenative properties of reprogramming from dedifferentiation is a promising prospect, termed epigenetic rejuvenation. Reprogramming-induced rejuvenation strategies currently involve using Yamanaka factors (typically transiently expressed to prevent full dedifferentiation) and are promising candidates to safely reduce biological age. Here, we review the development and potential of reprogramming-induced rejuvenation as an anti-ageing strategy.


Subject(s)
Aging/genetics , Cellular Reprogramming/genetics , Cellular Senescence/genetics , DNA Methylation/genetics , Epigenesis, Genetic , Epigenomics , Rejuvenation/physiology , Aged , Aged, 80 and over , Female , Humans , Male
4.
Methods Mol Biol ; 2272: 45-63, 2021.
Article in English | MEDLINE | ID: mdl-34009608

ABSTRACT

5-Hydroxymethylcytosine (5hmC) is an abundant DNA modification in human and mouse brain, as well as in embryonic stem cells, while severely depleted in multiple types of cancer. Assays for 5hmC detection and quantification, both on a locus-specific and global level, are limited in number and often resource-intensive. Immunodetection of 5hmC through antibodies remains a cost-effective and widely accessible approach. This chapter describes an ELISA-based protocol for 5hmC detection and quantification in genomic or in vitro modified DNA. It is based on the passive adsorption of DNA onto a solid polystyrene surface and the specific detection of 5hmC, which generates a measurable chemiluminescent signal, proportional to the amount of immobilized 5hmC. The assay utilizes a standard curve for interpolation of 5hmC percentage and a loading standard for monitoring loading precision.


Subject(s)
5-Methylcytosine/analogs & derivatives , DNA Methylation , DNA/analysis , Enzyme-Linked Immunosorbent Assay/methods , 5-Methylcytosine/chemistry , 5-Methylcytosine/immunology , Antibodies/immunology , DNA/chemistry , DNA/genetics , Genomics , Humans
5.
Methods Mol Biol ; 2272: 65-76, 2021.
Article in English | MEDLINE | ID: mdl-34009609

ABSTRACT

The enzyme-linked immunosorbent assay (ELISA) technique has been developed half a century ago, and yet its role in molecular biology remains significant. Among the most sensitive of immunoassays, it offers high throughput, combined with affordability and ease of use. This chapter provides the procedure of a highly reproducible indirect sandwich ELISA protocol, which can be applied to a variety of semi-quantitative assays for the investigation of the molecular biology of 5-hydroxymethylcytosine (5hmC) or TET enzymes. Three variations of this protocol are described: assessment and validation of 5hmC-binding proteins, screening and validation of anti-5hmC antibodies, or a readout of TET catalytic activity in in vitro experiments. The assay principle is based on the use of a high affinity avidin-biotin system for efficient immobilization of DNA fragments for further detection by high specificity antibodies. A colorimetric enzymatic reaction is ultimately developed with intensity correlating with the amount of attached antigen.


Subject(s)
5-Methylcytosine/analogs & derivatives , Avidin/chemistry , Biotin/chemistry , DNA Methylation , DNA/analysis , Enzyme-Linked Immunosorbent Assay/methods , Mixed Function Oxygenases/metabolism , Proto-Oncogene Proteins/metabolism , 5-Methylcytosine/chemistry , 5-Methylcytosine/immunology , Antibodies/immunology , DNA/chemistry , DNA/genetics , Genomics , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...